好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Pharmacokinetics of Conversion from Twice Daily Immediate-Release to Once Daily Extended-Release Lamotrigine (COMPASS Study)
Epilepsy
(-)
065
Authors/Disclosures
Imran I. Ali, MD, FAAN (University of Toledo COM) Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Hunan A. Chaudhry, MD No disclosure on file
No disclosure on file
No disclosure on file
Anne E. Hammer (Glaxo Welcome) No disclosure on file
Alain Vuong (GlaxoSmithKline) No disclosure on file
No disclosure on file
John A. Messenheimer, Jr., MD Dr. Messenheimer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zynerba Pharmaceuticals. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file